XI

InMoment Recognized for Artificial Intelligence Innovation in 2022 AI Breakthrough Awards for Best AI-Based Solution for Retail

Retrieved on: 
Tuesday, August 2, 2022
Data Management, Online Retail, Technology, Professional Services, Communications, Social Media, Apps, Applications, Retail, Data Analytics, Software, Artificial Intelligence, Natural language processing, Artificiality, Acquisition, Business intelligence, ROI, Intelligence, XI, Artificial intelligence, Social media, CX, General manager, Deep learning, NLP, Technology, Robotics, IM, Leadership, Machine learning, Heart, Program, API, AI, Medical device, Customer service

InMoment has been recognized for its work with one of the worlds largest outdoor clothing, equipment, and services retailers.

Key Points: 
  • InMoment has been recognized for its work with one of the worlds largest outdoor clothing, equipment, and services retailers.
  • We extend our sincere congratulations to the InMoment team for their well-deserved 2022 AI Breakthrough Award.
  • Part of Tech Breakthrough , a leading market intelligence and recognition platform for global technology innovation and leadership, the AI Breakthrough Awards program is devoted to honoring excellence in Artificial Intelligence technologies, services, companies, and products.
  • The AI Breakthrough Awards provide public recognition for the achievements of AI companies and products in categories including AI Platforms, Robotics, Business Intelligence, AI Hardware, NLP, Vision, Biometrics, and more.

Regional Center of Orange County Appoints Two New Board Members

Retrieved on: 
Wednesday, July 20, 2022
Intellectual, California Department of Developmental Services, Human, Special Areas Board, Dignity, XI, Applied behavior analysis, California Department, VAC, Inland Regional Center, State Council, Intellectual disability, Board, Developmental disability, Disability in Canada, Multimedia, California State University, Autism, Epilepsy, Cerebral palsy, Orange, List of counseling topics, Program, Original North American area codes, Residential care

SANTA ANA, Calif., July 20, 2022 /PRNewswire/ -- The Board of Directors of Regional Center of Orange County has appointed Anaheim's Yvonne Kluttz to serve a one-year term beginning July 1 and continuing through June 30, 2023. In addition, the organization's Vendor Advisory Committee (VAC) elected Rick Perez to serve as the VAC representative on the Board, from June 2 through May 31, 2023. Both are unpaid volunteer positions and the VAC position is a non-voting role.

Key Points: 
  • SANTA ANA, Calif., July 20, 2022 /PRNewswire/ -- The Board of Directors of Regional Center of Orange County has appointed Anaheim's Yvonne Kluttz to serve a one-year term beginning July 1 and continuing through June 30, 2023.
  • She also serves on the Consumer Advisory Committee for the California Department of Developmental Services and has served on Orange County's local Area Board XI and on the State Council on Developmental Disabilities .
  • About Regional Center of Orange County: Regional Center of Orange County is the private, nonprofit organization contracted by the State of California to coordinate lifelong services and supports for more than 23,000 Orange County residents with developmental disabilities and their families.
  • The Regional Center is the first stop for those seeking to obtain local services and supports to help them live safely and with dignity in the community.

Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer

Retrieved on: 
Monday, July 11, 2022
DOAC, Physician, Private Securities Litigation Reform Act, Anticoagulant, Harvard Medical School, Hematology, Apixaban, Thrombosis, FDA, Caregiver, Hemostasis, Fast Track, Regulation of tobacco by the U.S. Food and Drug Administration, ASTER, CVM, Therapy, Disease, Deep vein thrombosis, Priority review, VTE, XI, Program, Associate, SC, Bleeding, Food, ISTH, FXI, Factor, Accelerated approval (FDA), CAT, Stroke, The New England Journal of Medicine, Sodium, Anthos, Cancer, Pulmonary embolism, Congress, Risk, Multimedia, International Society, Death, Recurrence, Review, Factor XI, Patient, Research, Lists of diseases, AF, Atrial fibrillation, IV, White Light Rock & Roll Review, Pharmaceutical industry, Birth control

CAMBRIDGE, Mass., July 11, 2022 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its investigational Factor XI inhibitor, abelacimab, for the treatment of thrombosis associated with cancer. The company will also be announcing this important milestone today at a session of the ongoing 2022 Congress of the International Society on Thrombosis and Haemostasis (ISTH) Congress in London, UK.

Key Points: 
  • The Fast Track Designation process is designed to facilitate the development and expedite the review of treatments for serious medical conditions, thereby, addressing unmet medical needs.
  • "Fast track designation by the FDA is a significant milestone for abelacimab and Anthos Therapeutics, but more importantly represents another hopeful step forward for patients.
  • We look forward to working closely with the FDA on our clinical trial program to bring once-monthly abelacimab to patients in need."
  • "The hemostasis sparing potential of FXI inhibitors, such as abelacimab, may represent an important treatment advance in how we manage patients moving forward."

Anthos Therapeutics Announces that Abelacimab has Received FDA Fast Track Designation for the Treatment of Thrombosis Associated with Cancer

Retrieved on: 
Monday, July 11, 2022
DOAC, Physician, Private Securities Litigation Reform Act, Anticoagulant, Harvard Medical School, Hematology, Apixaban, Thrombosis, FDA, Caregiver, Hemostasis, Fast Track, Regulation of tobacco by the U.S. Food and Drug Administration, ASTER, CVM, Therapy, Disease, Deep vein thrombosis, Priority review, VTE, XI, Program, Associate, SC, Bleeding, Food, ISTH, FXI, Factor, Accelerated approval (FDA), CAT, Stroke, The New England Journal of Medicine, Sodium, Anthos, Cancer, Pulmonary embolism, Congress, Risk, International Society, Death, Recurrence, Review, Factor XI, Patient, Research, Lists of diseases, AF, Atrial fibrillation, IV, White Light Rock & Roll Review, Pharmaceutical industry, Birth control

CAMBRIDGE, Mass., July 11, 2022 /PRNewswire/ -- Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its investigational Factor XI inhibitor, abelacimab, for the treatment of thrombosis associated with cancer. The company will also be announcing this important milestone today at a session of the ongoing 2022 Congress of the International Society on Thrombosis and Haemostasis (ISTH) Congress in London, UK.

Key Points: 
  • The Fast Track Designation process is designed to facilitate the development and expedite the review of treatments for serious medical conditions, thereby, addressing unmet medical needs.
  • "Fast track designation by the FDA is a significant milestone for abelacimab and Anthos Therapeutics, but more importantly represents another hopeful step forward for patients.
  • We look forward to working closely with the FDA on our clinical trial program to bring once-monthly abelacimab to patients in need."
  • "The hemostasis sparing potential of FXI inhibitors, such as abelacimab, may represent an important treatment advance in how we manage patients moving forward."

InMoment Releases Major Updates to XI Platform to Help Companies Deliver Integrated Experiences Across the Entire Customer Journey

Retrieved on: 
Tuesday, June 28, 2022
Data Management, Apps, Applications, Technology, Other Technology, Mobile, Wireless, Software, Artificial Intelligence, NLP, Acquisition, Heart, CEO, Machine learning, Workflow, Marketo, Feedback, Intelligence, Program, Growth, CX, Ecosystem, Industry, WCAG, HubSpot, Code of Federal Regulations, Slack, UX, Natural language processing, Data, Technology, Organization, Salesforce, XI, Algorithm, Collection, Sales, Online shopping, Retail

"In order to win in the experience economy, companies need to deliver integrated experiences across the entire customer journey.

Key Points: 
  • "In order to win in the experience economy, companies need to deliver integrated experiences across the entire customer journey.
  • We have made major investmentsboth through technological innovation and strategic acquisitions, to help our clients be able to design and deliver experience improvement at scale.
  • Reviews are now seamlessly integrated into the InMoment CX (customer experience) cloud and available for analysis, trending and comparison alongside other forms of customer feedback.
  • InMoment AI: Underpinning all XI applications is industry-leading InMoment AI, an intelligence engine powering both structured and unstructured analytics across the platform.

InMoment Named a Leader in People-Oriented Text Analytics Platforms Report for Q2, 2022

Retrieved on: 
Wednesday, June 22, 2022
Professional Services, Other Consumer, Consumer, Data Analytics, Technology, Other Technology, Software, People, Solution, CX, Heart, Technology, Research, Knowledge, Lexalytics, OOTB, General manager, VOC, MaritzCX, Forrester, AI, XI, Mobile phone, Tutoring

InMoment, the leading provider of Experience Improvement (XI) solutions, today announced it has been named a Leader in The Forrester Wave: People-Oriented Text Analytics Platforms, Q2, 2022.

Key Points: 
  • InMoment, the leading provider of Experience Improvement (XI) solutions, today announced it has been named a Leader in The Forrester Wave: People-Oriented Text Analytics Platforms, Q2, 2022.
  • Forrester Research, Inc. evaluated 13 of the most significant text analytics vendors across 29 evaluation criteria, and named InMoment along with only four other vendors as a Leader in the evaluation.
  • We are pleased to be named a Leader in Forresters People-Oriented Text Analytics Platforms report,'' says Mehul Nagrani, General Manager, AI Product & Technology.
  • The People-Oriented Text Analytics Platforms, Q2, 2022 report is available here .

InMoment Acquires Leading Customer Review Management Company ReviewTrackers to Bolster its Market-Leading XI Platform and Accelerate the Pursuit of Experience Improvement

Retrieved on: 
Thursday, June 16, 2022
Professional Services, Other Consumer, Consumer, Data Analytics, Technology, Other Technology, Software, Online, Solution, Heart, Review, NLU, Follow, Intelligence, Technology, Human, Natural language processing, CEO, Â, Research, LinkedIn, Ecosystem, Acquisition, Twitter, Life, NLP, Machine learning, XI, Retail

InMoment, the leading provider of Experience Improvement (XI) solutions, announced today it has completed the acquisition of ReviewTrackers, an award-winning customer review management software company.

Key Points: 
  • InMoment, the leading provider of Experience Improvement (XI) solutions, announced today it has completed the acquisition of ReviewTrackers, an award-winning customer review management software company.
  • ReviewTrackers empowers over 175,000+ business locations to better understand and manage their customer reviews across 100+ sites with their review management technology.
  • The acquisition of ReviewTrackers makes InMoment the first experience company to extend customer insights, analytics and action across the full customer lifecycleacknowledging that customer reviews often set the stage for customer experience.
  • ReviewTrackers solutions allow for analyzing, amplifying, and maximizing customer feedback to accelerate customer acquisition and improve customer retention while driving more authentic connections with customers.

Table XI Reaffirms Commitment to Product Innovation, Changes Name to TXI

Retrieved on: 
Thursday, June 2, 2022
XI, IOT, Culture, Growth, Male, Moxy, Engineering, GLOBE, CEO, TXI, Research, Digital technology, Technology, Creative industries, Management, Public relations, Online shopping

TXIs multidisciplinary team will continue to deliver innovation strategy , product innovation , and data products that people want to use.

Key Points: 
  • TXIs multidisciplinary team will continue to deliver innovation strategy , product innovation , and data products that people want to use.
  • TXI was founded in 2002 with a similar look to other technology consultancies: as a majority white, male, highly-educated custom software development company.
  • Experience: TXI designs digital product experiences rooted in in-depth end user research to create positive outcomes for clients, customers, and employees.
  • As TXI evolves, we renounced check-the-box delivery and reaffirmed our commitment to driving real results for our clients.

InMoment Executives to Participate in Upcoming Jefferies Software Conference

Retrieved on: 
Wednesday, May 25, 2022
Software, Technology, Telecommunications, VoIP, Heart, XI, Technology, Tutoring, Baking

Improving experiences is why InMoment exists.

Key Points: 
  • Improving experiences is why InMoment exists.
  • Our mission is to help our clients improve experiences at the intersection of valuewhere customer, employee, and business needs come together.
  • The heart of what we do is connect our clients with what matters most through a unique combination of data, technology, and human expertise.
  • With our hyper-modern technology platform, decades of domain authority, and global teams of experts, we uniquely deliver a focus on Experience Improvement (XI) to help our clients own the moments that matter.

InMoment Demonstrates Commitment to Disability Inclusion With the Industry’s First Accessibility Compliance

Retrieved on: 
Thursday, May 19, 2022
Professional Services, Data Management, Other Professional Services, Technology, Other Technology, Human Resources, Software, Case management, Allianz, Population, AODA, Value, Leadership, Disability, Human factors and ergonomics, Severe cognitive impairment, Disability discrimination act, Deafness, Workplace, WCAG, XI, Workforce, Culture, ADA, World Bank, Inclusion, Marketing, Equality, Philippe Douste-Blazy, AA, Compliance, Technology, Heart, Sodexo, Distribution, Microsoft, Diversity, 1998 True Value 500, World, CEO, Health insurance, Tutoring

The InMoment platform is fully WCAG 2.0 AA compliant in the areas of readability, contrast ratio, scalability, cognitive keyboard operation, and screen reader support.

Key Points: 
  • The InMoment platform is fully WCAG 2.0 AA compliant in the areas of readability, contrast ratio, scalability, cognitive keyboard operation, and screen reader support.
  • InMoment passed testing through Allianzs internal, independent accessibility group Allianz Ergonomics, as well as Blazie, a third-party, accessibility consulting firm.
  • Allianz recently rolled-out the InMoment solution with WCAG compliance to their customers with disabilities, while also providing Allianz employees with disabilities access to the full reporting and case management product suite.
  • At Allianz, we work relentlessly to promote Diversity, Equality & Inclusion and foster a culture of respect.